W. L. Gore & Associates, Inc. ("Gore"), a global materials science company, recently announced the commercial launch of the 0 ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Hovanesian: The first diagnosis is a good time to refer, because GA patients lose visual acuity somewhat predictably, as much ...

Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Outlook Therapeutics introduces Lytenava in Germany & UK for the treatment of wet AMD: Iselin, New Jersey Tuesday, June 3, 2025, 16:00 Hrs [IST] Outlook Therapeutics, Inc., a biop ...

LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) ...

Diabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular ...

LYTENAVATM is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Un ...